Research location

Jinan

Shandong, China

Published trials633

Site observations758

Linked trials published633

Page3 / 13

Research activity in Jinan

Shandong, China

CureCurrent currently publishes aggregate city-level research activity for this location: 633 trials and 758 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Jinan

633 linked trials · page 3 of 13

A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung CancerNCT06631989 · 2024-09-04 · 1 site observation

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)NCT06452277 · 2024-08-28 · 1 site observation

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.NCT06617936 · 2024-08-27 · 1 site observation

JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationNCT06416410 · 2024-08-07 · 1 site observation

A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene AbnormalityNCT06496490 · 2024-08-06 · 1 site observation

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)NCT06024746 · 2024-07-09 · 1 site observation

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung CancerNCT06498479 · 2024-07-04 · 1 site observation

Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.NCT06778382 · 2024-06-24 · 1 site observation

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)NCT06345729 · 2024-05-24 · 1 site observation

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled TrialNCT06093932 · 2024-04-07 · 1 site observation

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)NCT06312137 · 2024-04-03 · 1 site observation

D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 1 site observation

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in ChinaNCT06414655 · 2024-03-01 · 2 site observations

Phase IIIb Study of Ribociclib + ET in Early Breast CancerNCT05827081 · 2024-02-28 · 2 site observations

Effect of Metformin on Healthy Live Birth in Women With PrediabetesNCT06064669 · 2024-02-22 · 1 site observation

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung CancerNCT06225804 · 2024-02-22 · 1 site observation

A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPCNCT06241846 · 2024-02-22 · 1 site observation

A Study of ZL-1310 in Subjects With Small Cell Lung CancerNCT06179069 · 2024-01-23 · 1 site observation

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseNCT06189495 · 2023-12-30 · 1 site observation

A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC PatientsNCT06155084 · 2023-12-26 · 1 site observation

Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate CancerNCT06139575 · 2023-12-22 · 1 site observation

Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection FractionNCT06196086 · 2023-12-20 · 1 site observation

A Study of YL202 in Selected Patients With Advanced Solid TumorsNCT06107686 · 2023-12-15 · 4 site observations

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)NCT06170788 · 2023-12-15 · 2 site observations

A Study of SGN-CEACAM5C in Adults With Advanced Solid TumorsNCT06131840 · 2023-11-20 · 1 site observation

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)NCT05920356 · 2023-11-16 · 1 site observation

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583 · 2023-11-15 · 1 site observation

Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLCNCT06125041 · 2023-10-30 · 1 site observation

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsNCT05899608 · 2023-10-26 · 1 site observation

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.NCT06064812 · 2023-09-12 · 1 site observation

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung CanceNCT06043973 · 2023-09-01 · 1 site observation

An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's DiseaseNCT05908695 · 2023-08-31 · 2 site observations

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsNCT05914116 · 2023-08-17 · 2 site observations

Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate CancerNCT06702995 · 2023-04-19 · 1 site observation

Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung CancerNCT05765877 · 2023-03-01 · 1 site observation

JAB-2485 Activity in Adult Patients With Advanced Solid TumorsNCT05490472 · 2022-12-20 · 1 site observation

Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLCNCT06241807 · 2022-12-02 · 1 site observation

A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid TumorsNCT05461768 · 2022-08-09 · 1 site observation

Patient's Whole Process Follow-up Management(HOPE-1)NCT05339568 · 2022-05-22 · 1 site observation

Multi-center Study on New Cardiovascular Remodeling and Function Parameters in HypertensionNCT05638503 · 2022-05-01 · 1 site observation

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C MutationNCT05288205 · 2022-04-14 · 2 site observations

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT04928846 · 2022-03-25 · 2 site observations

Application of AI Technology for the Diagnosis and Treatment of Geriatric DiseasesNCT06295263 · 2022-03-01 · 1 site observation

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsNCT05150691 · 2022-01-31 · 3 site observations

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerNCT05851014 · 2022-01-14 · 3 site observations

The Clinical Efficacy of Immunomodulators in RA PatientsNCT05626348 · 2021-12-22 · 1 site observation

Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated CardiomyopathyNCT07527715 · 2021-12-01 · 1 site observation

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid TumorsNCT05024214 · 2021-11-15 · 1 site observation

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)NCT05099172 · 2021-10-25 · 2 site observations

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast CancerNCT04790305 · 2021-06-18 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.